Golden Throat successfully coughs up $108m IPO

The Chinese throat lozenges maker overcame turbulent markets to complete its Hong Kong IPO after trading in a quarter of A-share-listed companies was suspended.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES